Propanc Biopharma Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Propanc Biopharma Inc
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
/ 
Frequently asked questions
To buy Propanc Biopharma Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Propanc Biopharma Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Propanc Biopharma Inc is PPCB:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Propanc Biopharma Inc has its primary listing on NASDAQ (Small cap). You can trade Propanc Biopharma Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Propanc Biopharma Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Propanc Biopharma Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Propanc Biopharma Inc.